Apex Frozen Foods Ltd
NSE: APEX BSE: 540692
Incorporated in 1995, Apex Frozen Foods Ltd is in the business of processing and exporting of Shrimps[1]
₹427
52W: ₹203 — ₹514
PE 42.9 · Book ₹163 · +162% vs bookMarket Cap₹1,334 Cr
Stock P/E42.9Price to Earnings
ROCE2.43%Return on Capital
ROE0.76%Return on Equity
Div. Yield0.46%Face Value ₹10
Strengths
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has been maintaining a healthy dividend payout of 75.2%
Weaknesses
- −Stock is trading at 2.57 times its book value
- −The company has delivered a poor sales growth of -0.33% over past five years.
- −Company has a low return on equity of 3.65% over last 3 years.
- −Earnings include an other income of Rs.16.8 Cr.
Shareholding Pattern
Promoters72.62%
FIIs6%
DIIs0.66%
Public20.73%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 72.62% | 72.62% | 72.62% | 72.62% | 72.62% | 72.62% | 72.62% | 72.62% |
| FIIs | 1.27% | 2.43%▲1.2 | 3.37%▲0.9 | 3.29%▼0.1 | 4.18%▲0.9 | 4.84%▲0.7 | 4.74%▼0.1 | 6%▲1.3 |
| DIIs | 0.22% | 0.76%▲0.5 | 0.37%▼0.4 | 0.44%▲0.1 | 0.55%▲0.1 | 0.55% | 0.55% | 0.66%▲0.1 |
| Public | 25.86% | 24.18%▼1.7 | 23.64%▼0.5 | 23.65%▲0.0 | 22.64%▼1.0 | 21.97%▼0.7 | 22.08%▲0.1 | 20.73%▼1.3 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 241 | 148 | 162 | 186 | 200 | 231 | 197 | 258 | 238 | 264 |
| Expenses | 222 | 140 | 160 | 175 | 196 | 227 | 191 | 243 | 227 | 251 |
| Operating Profit | 19 | 8 | 1 | 11 | 4 | 4 | 7 | 15 | 11 | 13 |
| OPM % | 8% | 6% | 1% | 6% | 2% | 2% | 3% | 6% | 5% | 5% |
| Net Profit | 8 | 3 | 0 | 4 | -2 | 0 | 2 | 9 | 12 | 10 |
| EPS ₹ | 2.67 | 0.95 | -0.12 | 1.22 | -0.53 | -0.07 | 0.63 | 2.91 | 3.8 | 3.23 |
AI Insights
Revenue Trend
TTM revenue at ₹958Cr, up 17.7% YoY. OPM at 5%.
Debt Position
Borrowings at ₹41Cr. Debt-to-equity ratio: 0.09x. Healthy balance sheet.
Capex Cycle
CWIP at ₹1Cr (0% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.66% (-3.85pp change). FIIs: 6% (+5.98pp change). Promoters hold 72.62%.
Margin & Efficiency
ROCE declining from 28% (Mar 2014) to 2% (Mar 2025). Working capital days: 110.
Valuation
PE 42.9x with 2.43% ROCE. Price is 162% above book value of ₹163. Dividend yield: 0.46%.
Recent Announcements
- Closure of Trading Window 30 Mar - Trading window closed from 01-Apr-2026 until 48 hours after audited Q4/FY2026 results declaration.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 23 Feb - Submission of Transcript of Q3FY26 Earnings Conference call held on 16th February, 2026
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 16 Feb - Audio of investors' conference call (16 Feb 2026) on Q3/9M results posted online.
- Announcement under Regulation 30 (LODR)-Investor Presentation 13 Feb
- Outcome Of Board Meeting-Financial Results 11 Feb
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse